Factors involved in sudden coagulation observed in patients with acute myocardial infarction

In Vivo

Volumn 26, Issue 6, 2012, Pages 1021-1025

  Pinelli, Arnaldo ^a   Trivulzio, Silvio ^a   Rossoni, Giuseppe ^a   Redaelli, Rosaria ^b   Brenna, Sergio ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Acute myocardial infarction (AMI); Antithrombin III; Coronary artery diseases (CAD); Matrix metalloproteinase 9 (MMP 9); Neutrophil gelatinase associated lipocalin (NGAL); Unstable atherosclerotic plaque

Indexed keywords

ANTITHROMBIN III; GELATINASE B; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEINASE; PROTHROMBIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; MALE; PREDICTION; PROTEIN BLOOD LEVEL; THROMBOSIS;

EID: 84872179462     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Robbins and Cotran: Pathological Basis of Diseases, In: Kumar V, Abbas AK, Fausto N (eds.). Philadelphia, USA, Elsevier Saunders, 7th edition, pp. 516-525, 571-586, 2005.
2. Libby A: Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.
3. Hansson GK: Inflammation, atherosclerosis and coronary disease. N Engl J Med 352: 1685-1695, 2005.
4. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstrom J and Fuster V: Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92: 1565-1569, 1995.
5. Falk E, Shah PK and Fuster V: Coronary plaque disruption. Circulation 92: 657-671, 1995.
6. Badimon L, Chesebro JH and Badimon JJ: Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation 866(Suppl): III74-III85, 1992.
7. Davies MJ and Thomas AC: Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 53: 363-373, 1985.
8. Falk E: Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 50: 127-134, 1983.
9. Deguchi JO, Aikawa M, Tung CH, Aikawa E, Kim DE, Ntziachristos V, Weissleder R and Libby P: Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 114: 55-62, 2006.
10. Kjeldsen L, Bainton DF, Sengelov H and Borregaard N: Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 83: 799-807, 1994.
11. Lacy P and Eitzen G: Control of granule exocytosis in neutrophils. Frontiers in Bioscience 13: 5559-5570, 2008.
12. Stintzing S, Heuschmann P, Barbera L, Ocker M, Jung A, Kirchner T and Neureiter D: Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation, and apoptosis. Ann Vasc Surg 19: 310-319, 2005.
13. Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, Thoren P and Hansson GK: Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 26: 136-142, 2006.
14. Paramo JA: Prothrombin fragments in cardiovascular disease. Adv Clin Chem 51: 1-23, 2010.
15. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM and Rosenberg RD: Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 90(1): 61-68, 1994.
16. Moyssakis I, Vlahodimitris IE, Kanakis MA, Kapsimali V, Tsoucala C and Vaiopoulos GA: Behavior of coagulation factors and normal inhibitors of coagulation during the acute phase of myocardial infarction. Blood Coagulation & Fibrinolysis 21: 670-673, 2010.
17. Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Tsoufis C, Marinou K, Charakida M, Stefanadi E, Vavuranakis M, Latsios G and Stefanadis C: Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction. Int J Cardiol 115(2): 203-207, 2007.
18. Rottbauer W, Greten T, Muller-Bardorff M, Remppis A, Zehelein J, Grunig E and Katus HA: Troponin T: a diagnostic marker for myocardial infarction and minor cardiac cell damage. Eur Heart J 17(Suppl): F3-F8, 1996.
19. Fu Q, Zhu J and Van Eyk JE: Comparison of multiplex immunoassay platforms. Clin Chem 56: 314-318, 2010.
20. Zografos T, Haliassos A, Korovesis S, Giazitzoglou E, Voridis E and Katritsis D: Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease. Am J Cardiol 104: 917-920, 2009.
21. Pelzer H, Schwarz A and Stuber W: Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemos 65(2): 153-159, 1991.
22. Antithrombin: automated chromogenic assay for the quantitative determination of antithrombin in human citrated plasma on the IL coagulation systems. Instrumentation Laboratory, Milan.
23. Armitage P: Statistica Medica. Milano, Feltrinelli, X Edizione, 1991.
24. Giansante C, Fiotti N, Di Chiara A, Altamura N, Wasserman S, Fioretti P and Guarnieri G: In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers. J Cardiovascular Med 8: 602-607, 2007.
25. Sundstrom J, Evans JC, Benjamin EJ, Levy D, Larson M.G, Sawyer DB, Siwik DA, Colucci WS, Sutherland P, Wilson PW and Vasan RS: Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study. Circulation 109: 2850-2856, 2004.
26. Morishige K, Shimokawa H, Matsumoto Y, Eto Y, Uwatoku T, Abe K, Sueishi K and Takeshita A: Overexpression of matrix metalloproteinase-9 promotes intravascular thrombus formation in porcine coronary arteries in vivo. Cardiovascular Res 57: 572-585, 2003.
27. Belaaouaj AA, Li A, Wun TC, Welgus HG and Shapiro SD: Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J Biol Chem 275: 27123-27128, 2000.
28. van 't Veer C and Mann KG: Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem 272: 4367-4377, 1997.
29. Owens AP 3rd. and Mackman N: Tissue factor and thrombosis: The clot starts here. Thromb Haemos 104: 432-439, 2010.
30. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M., Hafner G, Meyer J, Cambien F and Tiret L: Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107: 1579-1585, 2003.
31. Sahinarslan A, Kocaman SA, Bas D, Akyel A, Ercin U, Zengin O and Timurkaynak T: Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease. Coronary Artery Disease 22: 333-338, 2011.
32. Yndestad A, Landro L, Ueland T, Dahl CP, Flo TH, Vinge LE, Espevik T, Froland SS, Husberg C, Christensen G, Dickstein K, Kjekshus J, Oie E, Gullestad L and Aukrust P: Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J 30: 1229-1236, 2009.
33. Leclercq A, Houard X, Philippe M, Ollivier V, Sebbag U, Meilhac O and Michel JB: Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leuk Biol 82: 1420-1429, 2007.
34. Yan L, Borregaard N, Kjeldsen L and Moses MA: The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276: 37258-37265, 2001.